HR-896: Reaffirming support of fundamental United States principles at the United Nations and encouraging the World Health Organization to embrace technological advancements in tobacco control.
Sponsored by: Rep. David Rouzer
Introduced In House on 03/11/2020
You have voted HR-896: Reaffirming support of fundamental United States principles at the United Nations and encouraging the World Health Organization to embrace technological advancements in tobacco control..
Securing America’s Medicine Cabinet Act of 2020 [S.3432]
A bill to support the advanced manufacturing technologies program of the Food and Drug Administration, to establish National Centers of Excellence in Advanced Pharmaceutical Manufacturing, and for other purposes.
S.3432: Securing America’s Medicine Cabinet Act of 2020
Sponsored by: Sen. Martha McSally
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/10/2020
Cure the Coronavirus Act [HB-6019]
Expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
HB-6019: Cure the Coronavirus Act
Sponsored by: Rep. Tony Cardenas
Introduced In House on 02/28/2020
Environmental Justice For All Act [HB-5986]
Establishes several environmental justice requirements, advisory bodies, and programs to address the disproportionate adverse human health or environmental effects of federal laws or programs on communities of color, low-income communities, or tribal and indigenous communities. Specifically, the bill prohibits disparate impacts on the basis of race, color, or national origin as discrimination. Aggrieved persons may seek legal remedy when faced with such discrimination. In addition, the bill directs agencies to follow certain requirements concerning
(continued...)
HB-5986: Environmental Justice For All Act
Sponsored by: Rep. Raul Grijalva
Committee Hearings Held. on 10/01/2020
Safe Medicine Act [HB-5982]
To direct the Secretary of Health and Human Services to study American dependence on Chinese pharmaceuticals and to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination.
HB-5982: Safe Medicine Act
Sponsored by: Rep. Tim Ryan
Introduced In House on 02/26/2020
Restore and Modernize Our National Labs Act [HB-5966]
Provides funding to the Department of Energy (DOE) for deferred maintenance, critical infrastructure needs, and modernization of National Laboratories. DOE shall submit, with the annual budget submission of the President through FY2025, a list of projects for which DOE will provide funding under this bill.
HB-5966: Restore and Modernize Our National Labs Act
Sponsored by: Rep. Robert Scott
Introduced In House on 02/25/2020
Safe Medicine Act [HB-5927]
To direct the Secretary of Health and Human Services to study American dependence on unsafe Chinese pharmaceuticals and to empower the Food and Drug Administration to mandate drug recalls in the case of critical contamination.
HB-5927: Safe Medicine Act
Sponsored by: Rep. Bill Posey
Introduced In House on 02/18/2020
Foreign Manufacturers Legal Accountability Act of 2019 [HB-3737]
To require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers.
HB-3737: Foreign Manufacturers Legal Accountability Act of 2019
Sponsored by: Rep. Matthew Cartwright
Referred To The Subcommittee On Livestock And Foreign Agriculture. on 08/09/2019
Transparency in Prescription Drug Advertising Act [HB-5894]
Requires that the list prices of drugs be included, as appropriate, in advertising for such drugs and directs the Department of Health and Human Services to issue department-wide guidance to that effect that is consistent with regulations issued by the Centers for Medicare & Medicaid Services (CMS) regarding drug price transparency. On May 10, 2019, the CMS issued a final rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency. The rule requires direct-to-consumer television advertisements for drugs and biologics
(continued...)
HB-5894: Transparency in Prescription Drug Advertising Act
Sponsored by: Rep. Ed Perlmutter
Introduced In House on 02/13/2020
HB-5882: To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.
Sponsored by: Sen. Roger Marshall
Introduced In House on 02/12/2020
You have voted HB-5882: To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes..
Fairness in Orphan Drug Exclusivity Act [S.3271]
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
S.3271: Fairness in Orphan Drug Exclusivity Act
Sponsored by: Sen. Jeanne Shaheen
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/11/2020
Veterans HOPE Act Veterans Heroin Overdose Prevention Examination Act [HB-5774]
Requires the Department of Veterans Affairs (VA) to complete a review of the deaths of all covered veterans who died from opioid overdoses during the five-year period preceding the enactment of this bill. Covered veterans are those who received VA hospital care or medical services during the five-year period preceding the death of the veteran. The VA shall report on the results of the review and make such report publicly available.
HB-5668: MODERN Labeling Act of 2020 Making Objective Drug Evidence Revisions for New Labeling Act of 2020
Sponsored by: Rep. Brett Guthrie
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 11/18/2020